Literature DB >> 18092184

Nestin expression in central nervous system germ cell tumors.

K Sakurada1, M Saino, W Mouri, A Sato, C Kitanaka, T Kayama.   

Abstract

Central nervous system (CNS) germ cell tumors constitute a unique class of rare tumors that mainly affect children and adolescents. These tumors are believed to originate from displaced primordial germ cells. Recently, results of treatment of germ cell tumors have improved with use of radiotherapy and combination chemotherapy. However, some tumors have proven refractory to intensive treatment with surgery, radiation, and combination chemotherapy. Nestin is an intermediate filament protein expressed in undifferentiated cells during CNS development and in CNS tumors and is used as a marker of immature elements of tumors, including brain tumor stem cells. In this study, we examined for the first time nestin expression in 19 CNS germ cell tumors (nine pure germinomas, five germinomas with syncytiotrophoblastic giant cells, one yolk sac tumor, one choriocarcinoma, one embryonal carcinoma, and two mature teratomas). Nestin was expressed in 14 cases but was not expressed in three pure germinomas and two mature teratomas. Clinically, nestin-negative tumors did not exhibit dissemination, while all tumors that exhibited dissemination also strongly expressed nestin protein. These findings suggest that the detection of nestin expression could be useful in the management of CNS germ cell tumors, as an auxiliary predictor of dissemination and/or progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092184     DOI: 10.1007/s10143-007-0115-3

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  13 in total

1.  Combined chemotherapy and radiation therapy for central nervous system germ cell tumors: preliminary results of a Phase II study of the Japanese Pediatric Brain Tumor Study Group.

Authors:  M Matsutani; Y Ushio; H Abe; J Yamashita; S Shibui; T Fujimaki; K Takakura; K Nomura; R Tanaka; M Fukui; T Yoshimoto; T Hayakawa; T Nagashima; K Kurisu; T Kayama
Journal:  Neurosurg Focus       Date:  1998-07-15       Impact factor: 4.047

2.  Immunohistochemical detection of nestin in pediatric brain tumors.

Authors:  Per M Almqvist; Richard Mah; Urban Lendahl; Björn Jacobsson; Glenda Hendson
Journal:  J Histochem Cytochem       Date:  2002-02       Impact factor: 2.479

3.  Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours.

Authors:  J Ehrmann; Z Kolár; J Mokry
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 4.  Nestin expression--a property of multi-lineage progenitor cells?

Authors:  C Wiese; A Rolletschek; G Kania; P Blyszczuk; K V Tarasov; Y Tarasova; R P Wersto; K R Boheler; A M Wobus
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

Review 5.  So-called intracranial germ cell tumours: personal experiences and a theory of their pathogenesis.

Authors:  K Sano; M Matsutani; T Seto
Journal:  Neurol Res       Date:  1989-06       Impact factor: 2.448

6.  Nestin as a marker for proliferative endothelium in gliomas.

Authors:  Ken-ichi Sugawara; Hideyuki Kurihara; Mitsuko Negishi; Nobuhito Saito; Yoichi Nakazato; Tomio Sasaki; Toshiyuki Takeuchi
Journal:  Lab Invest       Date:  2002-03       Impact factor: 5.662

Review 7.  Pathogenesis of intracranial germ cell tumors reconsidered.

Authors:  K Sano
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

8.  Nestin expression in neuroepithelial tumors.

Authors:  Davide Schiffer; Andrea Manazza; Ilaria Tamagno
Journal:  Neurosci Lett       Date:  2006-03-10       Impact factor: 3.046

9.  Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas.

Authors:  Maarit Sarlomo-Rikala; Tohru Tsujimura; Urban Lendahl; Markku Miettinen
Journal:  APMIS       Date:  2002-06       Impact factor: 3.205

10.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.

Authors:  Gentao Liu; Xiangpeng Yuan; Zhaohui Zeng; Patrizia Tunici; Hiushan Ng; Iman R Abdulkadir; Lizhi Lu; Dwain Irvin; Keith L Black; John S Yu
Journal:  Mol Cancer       Date:  2006-12-02       Impact factor: 27.401

View more
  4 in total

1.  Association of stem cell marker CD133 expression with dissemination of glioblastomas.

Authors:  Atsushi Sato; Kaori Sakurada; Toshihiro Kumabe; Toshio Sasajima; Takaaki Beppu; Kenichiro Asano; Hiroki Ohkuma; Akira Ogawa; Kazuo Mizoi; Teiji Tominaga; Chifumi Kitanaka; Takamasa Kayama
Journal:  Neurosurg Rev       Date:  2010-02-05       Impact factor: 3.042

2.  Primary CNS teratocarcinoma.

Authors:  Danilo Vitorovic; Jordan Rosenblum; Chinnamma Thomas; John Lee; José Biller
Journal:  Front Neurol       Date:  2012-02-06       Impact factor: 4.003

Review 3.  Nestin as a marker of cancer stem cells.

Authors:  Jakub Neradil; Renata Veselska
Journal:  Cancer Sci       Date:  2015-05-26       Impact factor: 6.716

4.  Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model.

Authors:  Sergey Malchenko; Simone Treiger Sredni; Yingtao Bi; Naira V Margaryan; Jerusha Boyineni; Indra Mohanam; Tadanori Tomita; Ramana V Davuluri; Marcelo B Soares
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.